Norbelpharma

Norbelpharma is a Spanish pharmaceutical company headquartered in Madrid that specializes in the commercialization, wholesale, and distribution of pharmaceutical products and medical devices. Operating as a subsidiary of Norbel Inversiones—the investment vehicle for the Gallardo family, who also control Almirall—the company plays a strategic role in the Iberian healthcare supply chain. Norbelpharma focuses on providing a range of hospital-grade medicines and generic formulations, including treatments for central nervous system disorders and general therapeutic needs. The company acts as a marketing authorization holder for various products, ensuring the availability of essential medications to pharmacies and healthcare institutions throughout Spain. Its business model leverages the extensive industry experience of its parent group to manage a diverse portfolio of therapeutic solutions.